Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Journal of Infectious Diseases Year : 2009

Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria.


Background. Although optimization of the fluoroquinolone dosage increases the efficacy of this class of drugs against bacterial infections, its impact on the emergence of resistance in commensal bacteria is unknown. Methods. Six different 14-day dosages of oral ciprofloxacin were randomly assigned to 48 healthy volunteers. Individual pharmacokinetic and pharmacodynamic parameters combining antibiotic exposure in plasma, saliva, and stool specimens and ciprofloxacin minimum inhibitory concentrations (MICs) and mutant prevention concentrations against viridans group streptococci in the pharyngeal flora and Escherichia coli in the fecal flora were estimated. Their links with the emergence of resistance to nalidixic acid or ciprofloxacin in the fecal flora and to levofloxacin in the pharyngeal flora 7, 14, or 42 days after ciprofloxacin initiation were investigated. Results. Resistance emerged in the fecal and pharyngeal flora of 25% and 33% of the subjects, respectively, mainly when local concentrations of ciprofloxacin were less than the MIC. No variable that integrated pharmacokinetic data and pharmacodynamic parameters was found to differ significantly between the subjects in whom resistance emerged and those in whom it did not. Probabilities of the emergence of resistance were not significantly different across the different antibiotic dosages. Conclusions. Selection of resistant commensals during ciprofloxacin therapy is a frequent ecological side effect that is not preventable by dosage optimization. Trial registration. Clinical identifier: NCT00190151 .
Fichier principal
Vignette du fichier
inserm-00409776_edited.pdf (254.74 Ko) Télécharger le fichier
fantin_cipro.pdf (209.09 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)

Dates and versions

inserm-00409776 , version 1 (02-08-2010)



Bruno Fantin, Xavier Duval, Laurent Massias, Loubna Alavoine, Françoise Chau, et al.. Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria.. Journal of Infectious Diseases, 2009, 200 (3), pp.390-398. ⟨10.1086/600122⟩. ⟨inserm-00409776⟩


175 View
916 Download



Gmail Facebook X LinkedIn More